Literature DB >> 3515117

Reduced hepatic insulin clearance in rats with dietary-induced obesity.

G Strömblad, P Björntorp.   

Abstract

Insulin uptake in the in situ perfused liver from rats that were moderately obese after overfeeding was diminished in comparison with controls. The obese rats had higher levels of portal free fatty acids (FFA) and liver triglyceride contents but not of insulin concentration in the portal vein. There were strong negative correlations between hepatic triglyceride and insulin clearance (r approximately 0.8-0.9). The perfusions were performed with lower FFA concentrations than those in vivo in the portal vein. It is suggested that the inhibited insulin uptake in the obese rats was due to exposure of these livers in vivo to elevated FFA concentrations, and that this inhibition remained during the experiment and was associated with the triglyceride contents of the livers. It is also suggested that this mechanism was responsible for the moderate peripheral hyperinsulinemia seen in these rats. A mechanism of regulation of insulin uptake in the liver via FFA and liver triglyceride might be of importance in several conditions with hyperinsulinemia and known elevation of portal FFA, and liver triglyceride contents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515117     DOI: 10.1016/0026-0495(86)90148-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  20 in total

Review 1.  Nonesterified fatty acids in blood pressure control and cardiovascular complications.

Authors:  B M Egan; E L Greene; T L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Hepatic but Not Extrahepatic Insulin Clearance Is Lower in African American Than in European American Women.

Authors:  Francesca Piccinini; David C Polidori; Barbara A Gower; Richard N Bergman
Journal:  Diabetes       Date:  2017-07-14       Impact factor: 9.461

4.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Authors:  Tiffany D Farmer; Erin C Jenkins; Tracy P O'Brien; Gregory A McCoy; Allison E Havlik; Erik R Nass; Wendell E Nicholson; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

5.  The effect of high-fat diet on the development of obesity and serum leptin level in rats.

Authors:  M Bahceci; A Tuzcu; M Akkus; M Yaldiz; A Ozbay
Journal:  Eat Weight Disord       Date:  1999-09       Impact factor: 4.652

6.  PPAR-γ receptor agonists-a review of their role in diabetic management in Trinidad and Tobago.

Authors:  Steve Ian Smith
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

7.  Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance.

Authors:  L F Rezende; G J Santos; J C Santos-Silva; E M Carneiro; A C Boschero
Journal:  Diabetologia       Date:  2012-02-19       Impact factor: 10.122

8.  Suppression of body weight gain preserves acute insulin response to glucose in the portal vein of spontaneously type 2 diabetic rats with visceral obesity.

Authors:  Yutaka Mori; Yoshirou Kitahara; Kyouko Miura; Yohta Itoh; Naoko Tajima
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

9.  Green tea consumption, abdominal obesity as related factors of lacunar infarction in Korean women.

Authors:  S-G Ko; H Go; S Sun; S Lee; W Park; Y Choi; Y Song; G Hwang; G Kim; C Jeon; J Park; K Lee; M Cha; O Bang; H Jung; N Kim; Y-C Shin
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

10.  Fatty acids in the portal vein of the rat regulate hepatic insulin clearance.

Authors:  J Svedberg; G Strömblad; A Wirth; U Smith; P Björntorp
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.